Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
[68Ga]Ga-SCH001
- Development stage
- Unknown
- Lead developer
- First Affiliated Hospital of Soochow University
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Peptides
- Administration
- Intravenous
01
Overview
[68Ga]Ga-SCH001 is a novel gallium-68 labeled cyclic peptide radiopharmaceutical that targets CD38. It is being developed as a positron emission tomography (PET) imaging tracer for the non-invasive visualization of CD38 expression, assessment of whole-body tumor burden, and monitoring of early therapeutic response in patients with multiple myeloma and other plasma cell disorders (such as POEMS syndrome). The tracer consists of the cyclic peptide SCH001, which has high affinity and specificity for CD38, conjugated to a chelator (such as NOTA) and radiolabeled with gallium-68. In clinical studies, [68Ga]Ga-SCH001 has demonstrated rapid blood clearance, favorable radiation dosimetry, and high-contrast imaging of focal skeletal lesions in multiple myeloma.
- Other names
- [68Ga]Ga-NOTA-SCH00168Ga-SCH001Ga-SCH001Ga-SCH-001Ga-SCH 001
02
Targets
CD38 (Cluster of Differentiation 38)
Beyond the preview
Go deeper on [68Ga]Ga-SCH001.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on [68Ga]Ga-SCH001.